VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 11, 2015) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" and "the Company") is pleased to announce that Graeme Watson has been appointed to the Company's Board of Directors. Mr. Watson is a proven business leader with a track record of delivering growth in a profitable manner.

Graeme Watson was most recently the President and CEO of Infosat Communications ("Infosat"), Canada's leader in satellite communications solutions. Under his leadership, Infosat's technical capabilities were significantly enhanced, and the company continued achieving impressive growth. Mr. Watson's strategic vision, including through the recent financial crisis, helped ensure that Infosat's position as industry leader was further strengthened and will be sustained into the future. During his tenure, he was instrumental in establishing key commercial relationships with industry giants such as AT&T and Cisco, and in pioneering the implementation of new technologies that are relied upon in mission-critical environments by some of Canada's most significant enterprises.

"I am very pleased to be joining the board of directors of Calyx," commented Mr. Watson. "The recent acquisition of Cannigistics is an exciting step for the Company in charting its path forward, and I look forward to supporting management in achieving its goals."

"Graeme Watson is an excellent addition to the Calyx board of directors," said Don Konantz, CEO of Calyx. "His experience in building and running a significant enterprise will prove valuable as the Company grows. He brings to the table relevant insight that complements the skills and experience of the current directors and management team."

About Calyx

Calyx's wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement. Calyx also has a significant shareholding in Agrisoma Biosciences Inc., a company which is commercializing carinata, a non-food energy feedstock crop, for biofuel production.

For further information about Calyx, please visit


Don Konantz, Director, President and Chief Executive Officer

Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.

Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.

The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

Calyx Bio-Ventures Inc.
Don Konantz
President & CEO